Patrick M. Sweeney & Associates’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$383K Buy
1,310
+15
+1% +$4.93K 0.25% 105
2025
Q4
$454K Sell
1,295
-93
-7% -$31.4K 0.28% 82
2025
Q3
$448K Hold
1,388
0.29% 80
2025
Q2
$483K Buy
1,388
+30
+2% +$12.1K 0.33% 78
2025
Q1
$590K Buy
1,358
+15
+1% +$6.02K 0.44% 58
2024
Q4
$495K Buy
1,343
+25
+2% +$10.5K 0.37% 71
2024
Q3
$685K Buy
1,318
+57
+5% +$30.5K 0.5% 49
2024
Q2
$683K Buy
1,261
+13
+1% +$6.87K 0.55% 46
2024
Q1
$647K Buy
1,248
+30
+2% +$14.9K 0.53% 46
2023
Q4
$574K Buy
+1,218
New +$563K 0.53% 46

Other funds holding ELV

Patrick M. Sweeney & Associates's ELV Position: Q1 2026 in Review

Patrick M. Sweeney & Associates increased its Elevance Health (ELV) stake by 1.2% in Q1 2026, buying an estimated $4.93K and bringing the position to 1,310 shares worth $383K. The position accounts for 0.25% of the portfolio, ranked #105.

Patrick M. Sweeney & Associates first reported a position in ELV in Q4 2023 and has held it in 10 quarters since. The position peaked at $685K in Q3 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Patrick M. Sweeney & Associates held 1,310 shares of Elevance Health worth $383K as of Q1 2026.
  • Patrick M. Sweeney & Associates bought 15 Elevance Health shares in Q1 2026, an estimated $4.93K.
  • Elevance Health made up 0.25% of Patrick M. Sweeney & Associates's portfolio in Q1 2026, its #105 holding.
  • Patrick M. Sweeney & Associates first reported a position in Elevance Health in Q4 2023 and has held it in 10 quarters since.
  • Patrick M. Sweeney & Associates's Elevance Health position peaked at $685K in Q3 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Patrick M. Sweeney & Associates's 13F filing for Q1 2026, filed 7 May 2026.